Monte Rosa Therapeutics, Inc. — Institutional Ownership
Which tracked institutions hold GLUE, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
25
Funds holding
$378108613
Total value held
Buying
16 added/new · 7 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $165602706 | 6843087 | +1205403 | +21.38% |
| 2 | State Street Corp | $90300267 | 3731416 | +377436 | +11.25% |
| 3 | Goldman Sachs Group Inc | $24157723 | 998253 | -3274 | -0.33% |
| 4 | Morgan Stanley | $19106990 | 789545 | +105482 | +15.42% |
| 5 | Northern Trust Corp | $15780505 | 652087 | -174537 | -21.11% |
| 6 | Janus Henderson Group Plc | $11293772 | 685926 | +685926 | NEW BUY |
| 7 | Ameriprise Financial Inc | $9276708 | 383335 | +383335 | NEW BUY |
| 8 | Alphabet Inc. | $9013871 | 372474 | -311801 | -45.57% |
| 9 | Bank Of America Corp /De/ | $6160376 | 254561 | -132981 | -34.31% |
| 10 | Bank Of New York Mellon Corp | $5385007 | 222521 | +17834 | +8.71% |
| 11 | Ubs Group Ag | $4860159 | 200833 | +200833 | NEW BUY |
| 12 | Franklin Resources Inc | $4569759 | 188833 | -10889 | -5.45% |
| 13 | Citigroup Inc | $3133102 | 129467 | +118781 | +1111.56% |
| 14 | Invesco Ltd. | $2347714 | 97013 | +97013 | NEW BUY |
| 15 | Jpmorgan Chase & Co | $1835998 | 76820 | +9284 | +13.75% |
| 16 | Wells Fargo & Company/Mn | $1661330 | 68650 | +45439 | +195.76% |
| 17 | Sei Investments Co | $1210681 | 50028 | -27653 | -35.60% |
| 18 | Principal Financial Group Inc | $1185824 | 49001 | +6610 | +15.59% |
| 19 | Barclays Plc | $834102 | 34467 | +23114 | +203.59% |
| 20 | Prudential Financial Inc | $289795 | 11975 | -44305 | -78.72% |
| 21 | Royal Bank Of Canada | $76000 | 3164 | +996 | +45.94% |
| 22 | Fifth Third Bancorp | $14423 | 596 | — | Held |
| 23 | Pnc Financial Services Group, Inc. | $11059 | 457 | — | Held |
| 24 | Us Bancorp \De\ | $702 | 29 | +17 | +141.67% |
| 25 | Amalgamated Financial Corp. | $40 | 2832 | +2832 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.